WT
TEVA icon

Whittier Trust’s Teva Pharmaceuticals TEVA Stock Holding History

Whittier Trust’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-725
Closed -$12.1K – 1600
2025
Q2 		$12.1K Hold
725
– – ﹤0.01% 1204
2025
Q1 		$11.1K Hold
725
– – ﹤0.01% 1205
2024
Q4 		$16K Hold
725
– – ﹤0.01% 1166
2024
Q3 		$13.1K Sell
725
-353
-33% -$6.18K ﹤0.01% 1220
2024
Q2 		$17.5K Hold
1,078
– – ﹤0.01% 1120
2024
Q1 		$15.2K Sell
1,078
-340
-24% -$4.29K ﹤0.01% 1193
2023
Q4 		$14.8K Hold
1,418
– – ﹤0.01% 1165
2023
Q3 		$14.5K Hold
1,418
– – ﹤0.01% 1185
2023
Q2 		$10.7K Sell
1,418
-33
-2% -$268 ﹤0.01% 1258
2023
Q1 		$12.8K Hold
1,451
– – ﹤0.01% 1250
2022
Q4 		$13.2K Hold
1,451
– – ﹤0.01% 1238
2022
Q3 		$12K Hold
1,451
– – ﹤0.01% 1314
2022
Q2 		$11K Sell
1,451
-102
-7% -$889 ﹤0.01% 1310
2022
Q1 		$15K Hold
1,553
– – ﹤0.01% 1271
2021
Q4 		$12K Hold
1,553
– – ﹤0.01% 1292
2021
Q3 		$15K Sell
1,553
-800
-34% -$7.49K ﹤0.01% 1188
2021
Q2 		$23K Sell
2,353
-408
-15% -$4.32K ﹤0.01% 1118
2021
Q1 		$32K Sell
2,761
-117
-4% -$1.34K ﹤0.01% 1039
2020
Q4 		$28K Sell
2,878
-12
-0.4% -$115 ﹤0.01% 967
2020
Q3 		$26K Buy
2,890
+764
+36% +$8.08K ﹤0.01% 952
2020
Q2 		$26K Sell
2,126
-800
-27% -$9.05K ﹤0.01% 922
2020
Q1 		$26K Buy
2,926
+36
+1% +$369 ﹤0.01% 933
2019
Q4 		$28K Sell
2,890
-3,947
-58% -$35.2K ﹤0.01% 961
2019
Q3 		$47K Sell
6,837
-55
-0.8% -$421 ﹤0.01% 846
2019
Q2 		$63K Hold
6,892
– – ﹤0.01% 758
2019
Q1 		$108K Buy
6,892
+1,411
+26% +$24.9K ﹤0.01% 643
2018
Q4 		$84K Buy
5,481
+1,434
+35% +$29.4K ﹤0.01% 674
2018
Q3 		$88K Sell
4,047
-415
-9% -$9.63K ﹤0.01% 662
2018
Q2 		$109K Sell
4,462
-340
-7% -$6.93K ﹤0.01% 613
2018
Q1 		$82K Sell
4,802
-1,053
-18% -$20.6K ﹤0.01% 679
2017
Q4 		$111K Sell
5,855
-3,355
-36% -$50.5K ﹤0.01% 605
2017
Q3 		$162K Sell
9,210
-2,714
-23% -$61.1K 0.01% 533
2017
Q2 		$396K Sell
11,924
-515
-4% -$15.9K 0.02% 373
2017
Q1 		$399K Buy
12,439
+555
+5% +$18.9K 0.02% 368
2016
Q4 		$431K Sell
11,884
-1,593
-12% -$63.6K 0.02% 361
2016
Q3 		$620K Sell
13,477
-1,110
-8% -$57.9K 0.03% 319
2016
Q2 		$732K Hold
14,587
– – 0.03% 296
2016
Q1 		$780K Sell
14,587
-1,361
-9% -$79.9K 0.03% 284
2015
Q4 		$1.05M Sell
15,948
-259
-2% -$16K 0.05% 259
2015
Q3 		$915K Sell
16,207
-1,693
-9% -$110K 0.04% 261
2015
Q2 		$1.06M Sell
17,900
-278
-2% -$17.1K 0.05% 269
2015
Q1 		$1.13M Sell
18,178
-1,147
-6% -$66.7K 0.05% 247
2014
Q4 		$1.11M Sell
19,325
-145
-0.7% -$8.08K 0.05% 246
2014
Q3 		$1.05M Sell
19,470
-661
-3% -$35K 0.05% 238
2014
Q2 		$1.05M Sell
20,131
-1,567
-7% -$80.1K 0.05% 240
2014
Q1 		$1.15M Sell
21,698
-1,735
-7% -$80.2K 0.06% 220
2013
Q4 		$939K Sell
23,433
-66,906
-74% -$2.63M 0.05% 250
2013
Q3 		$3.41M Sell
90,339
-2,845
-3% -$111K 0.18% 135
2013
Q2 		$3.65M Buy
+93,184
New +$3.63M 0.2% 123

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Whittier Trust's TEVA Position: Q3 2025 in Review

Whittier Trust sold out of Teva Pharmaceuticals (TEVA) in Q3 2025, closing a stake of 725 shares — an estimated $12.1K sold.

Whittier Trust first reported a position in TEVA in Q2 2013 and held it in 49 quarters. The position peaked at $3.65M in Q2 2013. 550 funds tracked by Wall St. Rank hold TEVA as of Q3 2025.

  • Whittier Trust reported no remaining Teva Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Whittier Trust sold 725 Teva Pharmaceuticals shares in Q3 2025, an estimated $12.1K.
  • Whittier Trust first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 49 quarters.
  • Whittier Trust's Teva Pharmaceuticals position peaked at $3.65M in Q2 2013.
  • 550 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2025.

Based on Whittier Trust's 13F filing for Q3 2025, filed 31 Oct 2025.